Midazolam/Ketamine

咪达唑仑/氯胺酮

Report date: 2024/06/27 20:00:09

Base Information

Drug NameMidazolam/Ketamine
Drug Alias NameMELT-300MELT-101MELT-102MELT-100MELT-130 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsGlutamate [NMDA] receptor antagonists
TargetsGamma-aminobutyric acid A receptorGlutamate [NMDA] receptor
Therapy Area/IndicationsSedationCataractAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes MidazolamKetamine Hydrochloride
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMelt Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCatalent IncMelt Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSedationCataractAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A